McKesey J, Tovar-Garza A, Pandya AG (2020) Melasma Treatment: an evidence-based review. Am J Clin Dermatol 21(2):173–225
Neagu N, Conforti C, Agozzino M, Marangi GF, Morariu SH, Pellacani G, Persichetti P, Piccolo D, Segreto F, Zalaudek I et al (2022) Melasma treatment: a systematic review. J Dermatolog Treat 33(4):1816–1837
Article CAS PubMed Google Scholar
Del Rosario E, Florez-Pollack S, Zapata L Jr., Hernandez K, Tovar-Garza A, Rodrigues M, Hynan LS, Pandya AG (2018) Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma. J Am Acad Dermatol 78(2):363–369
Torbeck RL, Schilling L, Khorasani H, Dover JS, Arndt KA, Saedi N (2019) Evolution of the Picosecond laser: a review of literature. Dermatol Surg 45(2):183–194
Article CAS PubMed Google Scholar
Wong CSM, Chan MWM, Shek SYN, Yeung CK, Chan HHL (2021) Fractional 1064 nm Picosecond Laser in Treatment of Melasma and skin rejuvenation in asians, a prospective study. Lasers Surg Med 53(8):1032–1042
Feng J, Shen S, Song X, Xiang W (2023) Efficacy and safety of picosecond laser for the treatment of melasma: a systematic review and meta-analysis. Lasers Med Sci 38(1):84
Searle T, Ali FR, Al-Niaimi F (2022) The versatility of azelaic acid in dermatology. J Dermatolog Treat 33(2):722–732
Article CAS PubMed Google Scholar
Baliña LM, Graupe K (1991) The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 30(12):893–895
Verallo-Rowell VM, Verallo V, Graupe K, Lopez-Villafuerte L, Garcia-Lopez M (1989) Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol Suppl (Stockh) 143:58–61
Dayal S, Sahu P, Dua R (2017) Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life. J Cosmet Dermatol 16(1):35–42
Malik F, Hanif MM, Mustafa G (2019) Combination of oral tranexamic acid with topical 3% tranexamic acid versus oral tranexamic acid with topical 20% azelaic acid in the treatment of Melasma. J Coll Physicians Surg Pak 29(6):502–504
Pandya AG, Hynan LS, Bhore R, Riley FC, Guevara IL, Grimes P, Nordlund JJ, Rendon M, Taylor S, Gottschalk RW et al (2011) Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol 64(1):78–83 83.e71-72
Abdel Hay R, Mohammed FN, Sayed KS, Abd El Fattah NA, Ibrahim S (2020) Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched nd:YAG laser. Dermatol Ther 33(4):e13629
Article CAS PubMed Google Scholar
Ardigo M, Cameli N, Berardesca E, Gonzalez S (2010) Characterization and evaluation of pigment distribution and response to therapy in melasma using in vivo reflectance confocal microscopy: a preliminary study. J Eur Acad Dermatol Venereol 24(11):1296–1303
Article CAS PubMed Google Scholar
Chung JY, Lee JH, Lee JH (2016) Topical tranexamic acid as an adjuvant treatment in melasma: side-by-side comparison clinical study. J Dermatolog Treat 27(4):373–377
Article CAS PubMed Google Scholar
Sheth VM, Pandya AG (2011) Melasma: a comprehensive update: part II. J Am Acad Dermatol 65(4):699–714
Kwon SH, Na JI, Choi JY, Park KC (2019) Melasma: updates and perspectives. Exp Dermatol 28(6):704–708
Wang YJ, Lin ET, Chen YT, Chiu PC, Lin BS, Chiang HM, Huang YH, Wang KY, Lin HY, Chang TM et al (2020) Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female Asian patients with melasma. J Eur Acad Dermatol Venereol 34(3):624–632
Manuskiatti W, Yan C, Gulfan MCB, Techapichetvanich T, Wanitphakdeedecha R (2022) Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: a randomized, split-face, and controlled trial. Lasers Surg Med 54(10):1245–1250
Thiboutot D, Thieroff-Ekerdt R, Graupe K (2003) Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol 48(6):836–845
Kim EH, Kim YC, Lee ES, Kang HY (2007) The vascular characteristics of melasma. J Dermatol Sci 46(2):111–116
Article CAS PubMed Google Scholar
Kaur A, Bhalla M, Pal Thami G, Sandhu J (2020) Clinical efficacy of Topical Tranexamic Acid with Microneedling in Melasma. Dermatol Surg 46(11):e96–e101
Article CAS PubMed Google Scholar
Shakeeb N, Noor SM, Ullah G, Paracha MM (2018) Efficacy of intense pulse light therapy and tripple combination cream versus intense pulse light therapy and tripple combination cream alone in epidermal Melasma treatment. J Coll Physicians Surg Pak 28(1):13–16
Hassan AM, Elfar NN, Rizk OM, Eissa NY (2018) Pulsed dye laser versus intense pulsed light in melasma: a split-face comparative study. J Dermatolog Treat 29(7):725–732
Nazzaro-Porro M (1987) Azelaic acid. J Am Acad Dermatol 17(6):1033–1041
留言 (0)